The collaboration began with an evaluation of the possibility of incorporating various active drug substances from the cannabis plant into AKVANO®. The formulation work has been carried out in
The product under development is based on a topical medical cannabinoid that has been incorporated into the AKVANO® formulation platform. The successful development of the product will make it possible to administer the medical cannabinoid as a spray, locally and in the exact desired amount, which together ensures improved contact and optimal penetration of the active substance into the skin.
As part of the feasibility study, AKVANO® technology and cannabinoids were tested for compatibility, demonstrating that cannabinoids can be combined in the AKVANO® system as a homogeneous, uniform and stable formulation. Cannassure tested the degree of product penetration into the skin using known and accepted models and found significant penetration of active ingredients into skin tissue. This improved penetration may increase the therapeutic potential of the product. According to Cannassure, based on these results, the company will go ahead, accelerating the pace of development steps and conducting more advanced testing. Cannassure will implement the technology for the development and commercialization of sprayable medicinal cannabis products based on AKVANO®.
The common goal is to introduce innovative topical treatments to the fast-growing global market for medical cannabis products.
"We are very pleased with the positive outcome of the feasibility study, which confirms our previous high hopes. The result is an important milestone for
"We look forward to continued successful cooperation with Cannassure in the field of medical cannabis."
This disclosure contains information that
For more information, please contact
Phone: +46 72 50 70 369
E-mail: ola.holmlund@lipidor.se
Certified Adviser
Telephone: +46 76 85 32 822
E-mail: ca@corpura.se (ca@corpura.se?subject=Lipidor%20AB)
About
About
https://news.cision.com/lipidor/r/lipidor-announces-positive-outcome-of-feasibility-study-for-development-of-topical-medical-cannabis-,c3205231
https://mb.cision.com/Main/17081/3205231/1312574.pdf
(c) 2020 Cision. All rights reserved., source